Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Annovis Bio
Annovis Bio
Annovis Bio doses first subject in Phase III Parkinson’s trial
Clinical Trials Arena
Thu, 08/25/22 - 10:49 am
Annovis Bio
clinical trials
buntanetap
Parkinson's Disease
Annovis rises on Alzheimer’s froth
EP Vantage
Tue, 05/25/21 - 11:02 am
Annovis Bio
Alzheimer's disease
ANVS401
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Parkinson's Disease
drug development
AstraZeneca
Roche
Prothena
MeiraGTx
Annovis Bio
Sanofi
Alkahest
Peptron
SAGE Therapeutics
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins
Xconomy
Wed, 01/29/20 - 11:59 pm
Annovis Bio
IPOs
neurodegenerative disease